KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scansource (SCSC) Asset Writedowns and Impairment (2016 - 2025)

Scansource's Asset Writedowns and Impairment history spans 17 years, with the latest figure at $3.7 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment fell 14.01% year-over-year to $3.7 million; the TTM value through Dec 2025 reached $8.0 million, down 18.06%, while the annual FY2025 figure was $8.4 million, 0.41% changed from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $3.7 million at Scansource, up from $1.9 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $4.2 million in Q4 2024 and bottomed at -$1.0 million in Q3 2021.
  • The 5-year median for Asset Writedowns and Impairment is $1.4 million (2022), against an average of $1.4 million.
  • The largest annual shift saw Asset Writedowns and Impairment crashed 12737.5% in 2021 before it soared 3225.6% in 2023.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $1.9 million in 2021, then tumbled by 104.72% to -$92000.0 in 2022, then surged by 442.39% to $315000.0 in 2023, then skyrocketed by 1248.25% to $4.2 million in 2024, then decreased by 14.01% to $3.7 million in 2025.
  • Per Business Quant, the three most recent readings for SCSC's Asset Writedowns and Impairment are $3.7 million (Q4 2025), $1.9 million (Q3 2025), and $652000.0 (Q2 2025).